GIA
RXRX icon

GHP Investment Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

GHP Investment Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-350
Closed -$1.07K – 1450
2026
Q1 		$1.07K Hold
350
– – ﹤0.01% 1034
2025
Q4 		$1.43K Hold
350
– – ﹤0.01% 900
2025
Q3 		$1.71K Hold
350
– – ﹤0.01% 858
2025
Q2 		$1.77K Buy
+350
New +$1.72K ﹤0.01% 863

Other funds holding RXRX

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
KG
Kieckhefer Group Mequon, Wisconsin $246M AUM 51.29% 1-Year Est. Return
TMC
Themes Management Co Greenwich, Connecticut $151M AUM
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AWM
Accel Wealth Management Waverly, Iowa $444M AUM 31.14% 1-Year Est. Return

GHP Investment Advisors's RXRX Position: Q2 2026 in Review

GHP Investment Advisors sold out of Recursion Pharmaceuticals (RXRX) in Q2 2026, closing a stake of 350 shares — an estimated $1.07K sold.

GHP Investment Advisors first reported a position in RXRX in Q2 2025 and held it in 4 quarters. The position peaked at $1.77K in Q2 2025. 51 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • GHP Investment Advisors reported no remaining Recursion Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • GHP Investment Advisors sold 350 Recursion Pharmaceuticals shares in Q2 2026, an estimated $1.07K.
  • GHP Investment Advisors first reported a position in Recursion Pharmaceuticals in Q2 2025 and held it in 4 quarters.
  • GHP Investment Advisors's Recursion Pharmaceuticals position peaked at $1.77K in Q2 2025.
  • 51 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.